This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Purchase Article View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Google Scholar Articles by Usadi, R. S. Articles by Young, S. L. PubMed PubMed Citation Articles by Usadi, R. S. Articles by Young, S. L. Related Collections Female Endocrinology

Endometrial Development and Function in Experimentally Induced Luteal Phase Deficiency

Division of Reproductive Endocrinology and Infertility (R.S.U.), Carolinas Medical Center, Charlotte, North Carolina 28232; Division of Reproductive Endocrinology and Infertility (J.M.G.), United States Air Force Medical Center, Wright-Patterson Air Force Base, Dayton, Ohio 45433; Division of Reproductive Endocrinology and Infertility (B.A.L.), Greenville Hospital, Greenville, South Carolina 29605; Departments of Pathology (R.A.L.) and Obstetrics and Gynecology (M.A.F., S.L.Y.), Division of Reproductive Endocrinology and Fertility, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599; and Department of Pathology (R.J.Z.), Milton S. Hershey Medical Center, Hershey, Pennsylvania 17033

Address all correspondence and requests for reprints to: Rebecca S. Usadi, M.D., Carolinas Medical Center, Division of Reproductive Endocrinology and Infertility, P.O. Box 32861, Charlotte, North Carolina 28232-2861. E-mail: Rebecca.Usadi{at}carolinashealthcare.org.

Context: It is generally assumed that delayed endometrial development observed in luteal phase deficiency (LPD) is the result of abnormally low progesterone (P) levels. This hypothesis has never been tested by direct experiment.

Objective: Our objective was to evaluate the effects of P concentrations on human endometrium.

Design and Setting: A randomized trial was conducted at an academic medical center.

Subjects: Twenty-nine healthy, ovulatory 18- to 35-yr-old women participated.

Intervention: Endometrial samples were obtained from women in natural cycles and two groups of experimentally modeled cycles. Women undergoing modeled cycles were treated with GnRH agonist and a fixed physiological dose of transdermal estradiol, followed by randomization to 10 or 40 mg daily im P administration to achieve either normal circulating luteal P or 4-fold lower P concentrations, the latter representing an experimental model of LPD.

Main Outcome Measures: Tissue specimens, obtained after 10 days of P exposure, were analyzed by histological dating, immunohistochemistry, immunoblot, and real-time quantitative RT-PCR (qRT-PCR).

Results: Histological dating of endometrium, immunohistochemistry for endometrial integrins, and qRT-PCR analysis for nine putative functional markers showed no differences between the three groups. Preliminary data from Western analysis suggest that some proteins may be affected by low serum P concentrations.

Conclusions: Histological endometrial dating does not reflect circulating P concentrations and cannot serve as a reliable bioassay of the quality of luteal function. Assessment of selected functional markers by either immunohistochemistry or qRT-PCR is similarly insensitive to decreased circulating P. Preliminary evidence suggests that abnormally low luteal phase serum P concentrations may have important functional consequences not otherwise detected.